Technology area: Chemistry & Materials
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Berkley Medical Resources Inc. is currently addressing 1 pending office action within the Chemistry & Materials technology area. This action involves 1 distinct examiner and is located in 1 distinct art unit. The busiest examiner, PAUL, SHREYA, is managing 1 busiest examiner pending action. This 1 busiest examiner pending action is the only one currently pending for the company. The alignment of 1 distinct examiner and 1 distinct art unit indicates a narrow and specific focus in the company's current chemistry-related patent filings.
Because there is only 1 pending office action, the company's immediate patent strategy is concentrated on a single point of contact within the USPTO. This lack of diversification in examiners or art units means that the company's current patent prospects are tied to the evaluation of PAUL, SHREYA within that 1 distinct art unit. Practitioners should focus on the specific preferences and history of this 1 distinct examiner. The focus on 1 distinct art unit suggests a specific chemical or material science application is currently being evaluated by the USPTO.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PAUL, SHREYA | 1 | 100.0% | +0.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18598693 | DISSOLVABLE NANOCELLULOSE SHEET | PAUL, SHREYA | — |
| Art Unit | Apps |
|---|---|
| 1761 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18598693 | DISSOLVABLE NANOCELLULOSE SHEET | PAUL, SHREYA | 1761 | §103§112 | Non-Final OA | — | Pending | Mar 07, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialBerkley Medical Resources Inc. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Shreya Paul has the most, with 1 of Berkley Medical Resources Inc.'s pending office actions.
Mostly Chemistry & Materials (USPTO Tech Center 1700), based on where its pending office actions are examined.
